Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in klatskin tumor patients
Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in klatskin tumor patients
复制标题
DOI:
10.1002/hep.27885
复制
发表时间:
2015-09-01
期刊:
影响因子:
13.5
通讯作者:
Stein, Ulrike
中科院分区:
文献类型:
--
作者:
Lederer, Andri;Herrmann, Pia;Stein, Ulrike
Curative treatment of intrahepatic cholangiocarcinoma (ICC) and hilar cholangiocarcinoma (Klatskin tumors) is limited to surgical resection or orthotopic liver transplantation. However, not all patients benefit from a surgical approach and suffer from early tumor recurrence. Response to chemotherapy is generally poor and, until today, no targeted therapy could be established. Metastasis-associated in colon cancer 1 (MACC1) is a recently discovered regulator of the hepatocyte growth factor (HGF)/Met/mitogen-activated protein kinase pathway, which induces proliferation, migration, and invasion in cell culture, as well as metastasis in mice. MACC1 expression shows a significant correlation with Met expression in colon cancer tissue and is highly prognostic for occurrence of distant metastasis and survival in colon cancer patients. Thus, we aimed to measure the expression of MACC1, Met, and HGF messenger RNA in microdissected tumor tissue and corresponding normal liver tissue of 156 patients with Klatskin tumors (n=76) and ICC (n=80) using real-time quantitative reverse-transcriptase polymerase chain reaction. We used immunohistochemical staining to validate the results. MACC1 expression in tumor tissue of both tumor entities was significantly higher than in corresponding normal liver tissue (P